Cells routinely present peptide fragments from their proteome for immune surveillance, using major histocompatibility complex (MHC) proteins as a display window. In this study, researchers introduced viral peptides to be processed and displayed on cancer cells.

One molecule combines two approaches to waken dormant immunity against tumors by Laurel Oldach.